Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2015, Article ID 640171, 8 pages
http://dx.doi.org/10.1155/2015/640171
Research Article

Hepatic but Not CNS-Expressed Human C-Reactive Protein Inhibits Experimental Autoimmune Encephalomyelitis in Transgenic Mice

1Department of Medicine, The University of Alabama Birmingham, Birmingham, AL 35294, USA
2Davis School of Gerontology and Department of Biological Sciences, The University of Southern California, Los Angeles, CA 90089, USA
3Department of Pathology, The University of Alabama Birmingham, Birmingham, AL 35294, USA

Received 9 July 2015; Accepted 13 August 2015

Academic Editor: Ricard Cervera

Copyright © 2015 Tyler T Wright et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Hurlimann, G. J. Thorbecke, and G. M. Hochwald, “The liver as the site of C-reactive protein formation,” Journal of Experimental Medicine, vol. 123, no. 2, pp. 365–378, 1966. View at Publisher · View at Google Scholar · View at Scopus
  2. T. W. Du Clos, “Pentraxins: structure, function, and role in inflammation,” ISRN Inflammation, vol. 2013, Article ID 379040, 22 pages, 2013. View at Publisher · View at Google Scholar
  3. J. E. Volanakis, “Human C-reactive protein: expression, structure, and function,” Molecular Immunology, vol. 38, no. 2-3, pp. 189–197, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Rajs, Z. Finzi-Yeheskel, A. Rajs, and M. Mayer, “C-reactive protein concentrations in cerebral spinal fluid in gram-positive and gram-negative bacterial meningitis,” Clinical Chemistry, vol. 48, no. 3, pp. 591–592, 2002. View at Google Scholar · View at Scopus
  5. C. J. M. Sindic, D. Collet-Cassart, A. Depré, E. C. Laterre, and P. L. Masson, “C-reactive protein in serum and cerebrospinal fluid in various neurological disorders. Apparent local consumption during bacterial meningitis,” Journal of the Neurological Sciences, vol. 63, no. 3, pp. 339–344, 1984. View at Publisher · View at Google Scholar · View at Scopus
  6. T. W. Du Clos, C. Mold, P. Y. Paterson, J. Alroy, and H. Gewurz, “Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis,” Clinical and Experimental Immunology, vol. 43, no. 3, pp. 565–573, 1981. View at Google Scholar · View at Scopus
  7. W. M. Juma, A. Lira, A. Marzuk, Z. Marzuk, A. M. Hakim, and C. S. Thompson, “C-reactive protein expression in a rodent model of chronic cerebral hypoperfusion,” Brain Research, vol. 1414, pp. 85–93, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Duong, M. Nikolaeva, and P. J. Acton, “C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease,” Brain Research, vol. 749, no. 1, pp. 152–156, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer, “Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease,” Brain Research, vol. 887, no. 1, pp. 80–89, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. R. D. Wight, C. A. Tull, M. W. Deel et al., “Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases,” Biochemical and Biophysical Research Communications, vol. 426, no. 1, pp. 112–115, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. S. D. Mulder, C. E. Hack, W. M. Van Der Flier, P. Scheltens, M. A. Blankenstein, and R. Veerhuis, “Evaluation of intrathecal serum amyloid P (SAP) and C-reactive protein (CRP) synthesis in Alzheimer's disease with the use of index values,” Journal of Alzheimer's Disease, vol. 22, no. 4, pp. 1073–1079, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. E. G. McGeer, K. Yasojima, C. Schwab, and P. L. McGeer, “The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases,” Neurobiology of Aging, vol. 22, no. 6, pp. 843–848, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Ryberg, J. An, S. Darko et al., “Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics,” Muscle and Nerve, vol. 42, no. 1, pp. 104–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Hon, M. Hassan, S. J. Van Rensburg et al., “Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis,” British Journal of Nutrition, vol. 102, no. 9, pp. 1334–1340, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Ciliberto, R. Arcone, E. F. Wagner, and U. Rüther, “Inducible and tissue-specific expression of human C-reactive protein in transgenic mice,” The EMBO Journal, vol. 6, no. 13, pp. 4017–4022, 1987. View at Google Scholar · View at Scopus
  16. A. J. Szalai, S. Nataf, X.-Z. Hu, and S. R. Barnum, “Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein,” The Journal of Immunology, vol. 168, no. 11, pp. 5792–5797, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Szalai, C. T. Weaver, M. A. McCrory et al., “Delayed lupus onset in (NZB × NZW)F1 mice expressing a human C-reactive protein transgene,” Arthritis & Rheumatism, vol. 48, no. 6, pp. 1602–1611, 2003. View at Publisher · View at Google Scholar
  18. X.-Z. Hu, T. T. Wright, N. R. Jones et al., “Inhibition of experimental autoimmune encephalomyelitis in human C-reactive protein transgenic mice is FcγRIIB dependent,” Autoimmune Diseases, vol. 2011, Article ID 484936, 2011. View at Publisher · View at Google Scholar
  19. M. Mayford, M. E. Bach, Y.-Y. Huang, L. Wang, R. D. Hawkins, and E. R. Kandel, “Control of memory formation through regulated expression of a CaMKII transgene,” Science, vol. 274, no. 5293, pp. 1678–1683, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Liang, X. Li, and J. Clark, “Increased expression of Ca2+/calmodulin-dependent protein kinase IIα during chronic morphine exposure,” Neuroscience, vol. 123, no. 3, pp. 769–775, 2004. View at Publisher · View at Google Scholar
  21. X. Wang, C. Zhang, G. Szábo, and Q.-Q. Sun, “Distribution of CaMKIIα expression in the brain in vivo, studied by CaMKIIα-GFP mice,” Brain Research, vol. 1518, pp. 9–25, 2013. View at Publisher · View at Google Scholar
  22. M. Mayford, D. Baranes, K. Podsypanina, and E. R. Kandel, “The 3′-untranslated region of CaMKII alpha is a cis-acting signal for the localization and translation of mRNA in dendrites,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 23, pp. 13250–13255, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Kojima, J. Wang, I. M. Mansu, S. G. N. Grant, M. Mayford, and E. R. Kandel, “Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 9, pp. 4761–4765, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. A. R. Consiglio and A. B. Lucion, “Technique for collecting cerebrospinal fluid in the cisterna magna of non-anesthetized rats,” Brain Research Protocols, vol. 5, no. 1, pp. 109–114, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. W. T. Golde, P. Gollobin, and L. L. Rodriguez, “A rapid, simple, and humane method for submandibular bleeding of mice using a lancet,” Lab Animal, vol. 34, no. 9, pp. 39–43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. R. W. Kuhlmann, L. Librizzi, D. Closhen et al., “Mechanisms of C-reactive protein-induced blood-brain barrier disruption,” Stroke, vol. 40, no. 4, pp. 1458–1466, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Hsuchou, A. J. Kastin, P. K. Mishra, and W. Pan, “C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation,” Cellular Physiology and Biochemistry, vol. 30, no. 5, pp. 1109–1119, 2012. View at Publisher · View at Google Scholar
  28. C. Mineo, A. K. Gormley, I. S. Yuhanna et al., “FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase,” Circulation Research, vol. 97, no. 11, pp. 1124–1131, 2005. View at Google Scholar
  29. L. Zhang, S. Liu, T. T. Wright et al., “C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis,” The Journal of Immunology, vol. 194, no. 11, pp. 5243–5252, 2015. View at Publisher · View at Google Scholar